The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer… ...

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.

At a glance: Immunotherapy has redefined cancer treatment, but not all patients experience the same benefit when treated. New research in mice identifies how gut bacteria alter the body’s response to ...

Our educational programs advance Harvard Medical School's core mission to alleviate human suffering by nurturing a diverse group of leaders and future leaders in both clinical care and biomedical ...

25 Shattuck Street Boston, MA 02115 617-432-1000Mission and Values Privacy Policy Digital Accessibility Accessibility Contact HMS Jobs Harvard Medicine magazine Alumni ...

For Rogulja, an associate professor of neurobiology in the Blavatnik Institute at Harvard Medical School, an intriguing aspect of sleep is the loss of consciousness and awareness it brings, as the ...

Over the past several years, scientists have generated intriguing insights suggesting that variations in gut microbiomes—the collections of bacteria and other microbes in our digestive systems—may ...

Like musical sounds, different states of mind are defined by distinct, characteristic waveforms, recognizable frequencies and rhythms in the electrical field of the brain. When the brain is alert and ...

HMS Researcher to Lead $104 Million Federal Project Tackling Antibiotic Resistance Multi-institutional effort aims to develop technology to transform diagnosis, treatment of bacterial infections ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...